Riskpilot← Back to searchSign inGet full accessAwareness Pharma AB
ABActiveOrg 5568189475Economic activity was not specified by tax authority · NACE 0000Est. 20100 employees
Revenue 2024
SEK 0
EBITDA margin
—
-45% vs 2023
Equity ratio
-8081900.0%
Financial strength
Net profit 2024
SEK -20K
-50% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -19K | -45% |
| Net profit | SEK -20K | -50% |
| Total assets | SEK 1 | — |
| Equity | SEK -81K | -32% |
| Employees | 0 | — |
Legal name
Awareness Pharma AB
Org number
5568189475
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
14 september 2010
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva apoteksverksamhet och därtill hörande verksamhet, samt handel med värdepapper med därtill hörande verksamhet.
Address
Email
alexandrathornholmm@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −7 | −4 | −5 | −6 | −6 | −6 | −5 | −6 | −13 | −19 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | — | — |
| EBIT | −7 | −4 | −5 | −6 | −6 | −6 | −5 | −6 | −13 | −19 |
| Net financials | — | — | — | — | — | — | — | — | −0 | −1 |
| Profit before tax | −7 | −4 | −5 | −6 | −6 | −6 | −5 | −6 | −13 | −20 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | — | — |
| Net profit | −7 | −4 | −5 | −6 | −6 | −6 | −5 | −6 | −13 | −20 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 40 | 14 | 8 | 2 | 6 | 0 | 4 | 3 | 0 | 0 |
| Equity | −10 | −14 | −20 | −26 | −32 | −37 | −42 | −48 | −61 | −81 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — |
| Short-term debt | 50 | 28 | 28 | 28 | 38 | 38 | 46 | 51 | 61 | 81 |
| Total debt | 50 | 28 | 28 | 28 | 38 | 38 | 46 | 51 | 61 | 81 |
EBITDA margin
-1856200.0%
This company
15.8%
Market median
-11748201% vs market
20152024
Equity ratio
-8081900.0%
This company
38.2%
Market median
-21156906% vs market
20152024
Return on equity
-1957600.0%
This company
18.4%
Market median
-10639230% vs market
20152024
Net profit margin
-1957600.0%
This company
8.1%
Market median
-24168001% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KJ Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Board of Directors | 2025 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Awareness Pharma AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Jonas Thörnholm | Chief Executive Officer | 0 companies |
| Jörgen Asango Bladh | Board of Directors | 0 companies |
| Lars Oskar Fredrik Thörnholm | Deputy Board Member | 0 companies |
| Anna Maria Hedvall | Deputy Board Member | 0 companies |
| Alexandra Barbara Thörnholm | Board of Directors | 0 companies |